Similar Articles

Pandemic-Triggered Aberrant Drug Use may Cause Failure of Antiepileptic Therapy

Manolya Bergüzar Şekerlisoy, Aslıhan Taşkıran Sağ

DOI: 10.4274/tnd.2021.45804

Issue: 2021, Volume 27 - Supplement 1
0 1335

Guillain-Barré Syndrome and COVID-19 Vaccines: A Comment

Joob Beuy, Viroj Wiwanitkit

DOI: 10.4274/tnd.2021.47048

Issue: 2021, Volume 27 - Supplement 1
0 1212

A rare variant of Guillain-Barré syndrome: Isolated bilateral facial paralysis

Saniye Karabudak, Zeliha Matur, Aslı Yaman Kula, Vildan Güzel, Ferda İlgen Uslu

DOI: 10.55697/tnd.2024.151

Issue: 2024, Volume 30 - Issue 4
3068 2449

Characteristics of ischemic stroke during the COVID-19 pandemic

Mehmet Yalman, Fatma Münevver Gökyiğit, Zahide Mail Gürkan, Ridvan Yazgu

DOI: 10.55697/tnd.2025.253

Issue: 2025, Volume 31 - Issue 1
1574 1266

Lessons learned and paths forward: Navigating the social landscape of multiple sclerosis care in the second wave of COVID-19

Nazire Pınar Acar Ozen, Dilara Cilizoglu, Bernanur Toprak, Nartan Demirok, Yeliz Salci, Rana Karabudak, Umut Beşpinar, Aslı Tuncer

DOI: 10.55697/tnd.2025.347

Issue: 2025, Volume 31 - Issue 2
1356 1026

The impact of COVID-19 pandemic on adult individuals with neuromuscular disease

Muhammed Kılınç, Ender Ayvat, Özge Onursal Kılınç, Fatma Ayvat, Mert Doğan, Gülşah Sütçü Uçmak, Can Ebru Bekircan Kurt, Sevim Erdem Özdamar, Sibel Aksu Yıldırım, Ersin Tan

DOI: 10.55697/tnd.2025.358

Issue: 2025, Volume 31 - Issue 3
1329 893

Global infodemiological trends in Parkinson’s disease-associated sleep disorders: Long-term digital impact of the COVID-19 pandemic

Esra Demir Ünal, Selim Selçuk Çomoğlu

DOI: 10.55697/tnd.2026.611

Issue: 2026, Volume 32 - Issue 1
295 297